ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Insmed, Inc. (INSM)

NASDAQ

$150.04

$+4.46

(+3.05%)

Insmed, Inc. (INSM) Live Price Chart

Page last updated: 2026-02-13 19:37:00

Key Market Data

Market Cap	$32.00B
Open	$147.24
High	$212.75
Low	$2.64
Previous Close	$146.17
Price Change	$+4.46
Percentage Change	+3.05%
Volume	1M

Insmed, Inc. (INSM) Stock Price Today

Insmed, Inc. (INSM) is currently trading at $150.04 as of 2026-02-13 19:37:00, reflecting a +3.05% move ($+4.46) from the previous close.

In the short term, the stock has returned -579.58% over the past four weeks. Over the last 12 months, Insmed, Inc. has recorded a +90.72% price change, indicating a strong performance relative to the broader market.

Insmed, Inc. (INSM) 7-Day Stock Price Changes

Over the past seven days, Insmed, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $148.83 to the latest recorded price of $150.04, reflecting an intraday change of +3.05%. Daily movements highlight shifts in trading volume (1,252,675), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, INSM has delivered a -579.58% return over the past month and a +90.72% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy Insmed, Inc. (INSM)

You can buy and trade INSM on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for INSM and Execute Your Trade

Open the trading page, enter INSM in the search bar, select the amount of INSM you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Insmed, Inc. (INSM)?

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Insmed, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	1,271
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.insmed.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Insmed, Inc.?

The latest trading price for Insmed, Inc. (Common Stock) is $ 150.04, compared with a previous closing price of $ 146.17. That means the stock has moved +3.05% so far today. Intraday price updates and recent trading activity for INSM can be tracked on the live chart and quote section on this page.

2.Is Insmed, Inc. stock going up or down?

Looking at recent performances, INSM has returned -579.58% over the past month, +17.89% over the last six months and +90.72% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for Insmed, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does INSM currently sit relative to its 52-week high and low?

In the most recent 52-week period, Insmed, Inc. has traded between a low of $ 60.40 and a high of $ 212.75. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether INSM is currently nearer the top or the bottom of its one-year trading band.

4.How is Insmed, Inc. classified by sector and industry?

Insmed, Inc. is classified in the PHARMACEUTICAL PREPARATIONS sector. In practice, this means Insmed, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing INSM’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the PHARMACEUTICAL PREPARATIONS sector could influence Insmed, Inc.’s performance.

5.Where is Insmed, Inc. listed and how large is it by market value?

Insmed, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 32.00B, the company is classified as a Large-cap stock. Market cap gives a quick sense of Insmed, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does INSM's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -5.55 summarises how much profit Insmed, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Insmed, Inc.'s financial performance over time?

To follow Insmed, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how INSM is performing and how the market is responding.

8.When is Insmed, Inc. expected to report earnings?

Insmed, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for INSM, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Insmed, Inc.'s earnings reports?

Insmed, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether INSM is meeting, beating or missing expectations.

10.How can I stay informed about Insmed, Inc.'s results and guidance?

You can stay up to date on Insmed, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for INSM on this page helps you see how new information is being reflected in the stock.

11.Does Insmed, Inc. pay a regular cash dividend to its shareholders?

Insmed, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor INSM's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for INSM?

Based on the latest earnings data, INSM has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Insmed, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Insmed, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Insmed, Inc.?

Insmed, Inc. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is INSM valued in terms of P/E ratio and EPS?

Insmed, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -5.55. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Insmed, Inc.'s earnings. Comparing INSM's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Insmed, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

BrightSpring Health Services, Inc.

BTSG

Cadence Design Systems

CDNS

The Chef's Warehouse Inc.

Top Gainers

Browse today's leading gainers in the US stock market

Cloudastructure, Inc.

CSAI

Founder Group Limited

FGL

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

MYX

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

INSM-to-USD Calculator

Amount

INSM

USD

1 INSM = 150.039 USD